Advanced Healthcare Technologies, Inc. Announces Letter to Shareholders Highlighting Company Developments.Business Editors OMAHA Omaha, city, United States Omaha (ō`məhä, –hô), city (1990 pop. 335,795), seat of Douglas co., E Nebr., on the west bank of the Missouri River; inc. 1857. , Neb.--(BUSINESS WIRE)--Oct. 6, 2003 Advanced Healthcare Technologies (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :AVHC) today announced that Randall Sulhoff of Omaha, Nebraska “Omaha” redirects here. For other uses, see Omaha (disambiguation). Omaha is the largest city in the State of Nebraska, United States. It is the county seat of Douglas County.GR6 As of the 2000 census, the city had a population of 390,007. has issued the following letter dated October 6, 2003 to the shareholders. Dear Shareholders: On behalf of the Board of Directors of Advanced Healthcare Technologies, Inc., I would like to take this opportunity to report on my first month as your CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. and on the present "state of our business." The last few weeks have been extremely exciting in forging new relationships as we continue executing our business plan. As mentioned in previous press releases, we are undergoing several new corporate developments that will fast-forward our position in the global arena. The corporate office has been moved to Omaha, Nebraska, with changes made with our management communications, an automated ordering and inventory system, a central accounting, dealer involvement and 100% influence towards customer relationship management. At the end of September, AVHC contracted with Mr. Frederic Schwab as our European sales and marketing manager, headquartered in Germany. AVHC announced an exclusive licensing agreement with FSI FSI Foreign Service Institute FSI Fluid Structure Interaction FSI Fuel Stratified Injection FSI Federazione Scacchistica Italiana (Italian Chess Federation) FSI Free Standing Insert FSI Flight Simulator Nutrition for Hyper-02/p. Hyper-02/p is an amino acid amino acid (əmē`nō), any one of a class of simple organic compounds containing carbon, hydrogen, oxygen, nitrogen, and in certain cases sulfur. These compounds are the building blocks of proteins. product, which has been shown in medical research, to supplement tissue rejuvenation Rejuvenation Aeson in extreme old age, restored to youth by Medea. [Rom. Myth.: LLEI, I: 322] apples of perpetual youth by tasting the golden apples kept by Idhunn, the gods preserved their youth. [Scand. Myth. in conjunction with the Hyperbaric Chamber hyperbaric chamber or decompression chamber or recompression chamber Sealed chamber supplying a high-pressure atmosphere primarily for medical therapy. Breathing air or oxygen at typically 1. . In addition to new changes and new product lines, AVHC has two (2) acquisition targets. Both will enlarge the combined entities, annual revenues, plus tax credits and assets for the company. In regards to manufacturing, the Topical Hyperbaric Chamber is being re-designed by our founder Phillip Loori. Mr. Loori has started the process of filing both US and International patent applications for his new Disposable Flexible Topical Hyperbaric Oxygen hyperbaric oxygen n. Oxygen at a pressure that is above one atmosphere. Also called high-pressure oxygen. Hyperbaric oxygen Extremity Chamber. The unit being flexible will allow for ease of operation in treating nursing home patients as well as for patients being treated in home care. AVHC plans to begin three separate clinical studies in its efforts to obtain Medicare approval for its Topical Hyperbaric hyperbaric /hy·per·bar·ic/ (-bar´ik) having greater than normal pressure or weight; said of gases under greater than atmospheric pressure, or of a solution of greater specific gravity than another used as a reference standard. Therapy Products. These studies will quantify the results AVHC is currently seeing in the patients being treated. Phillip Loori, CEO of AVHC's subsidiary Advanced Hyperbaric Technologies, Inc. is involved in ongoing discussions with several companies in the wound care and oxygen field who have national sales forces in place in an effort to form a strategic marketing partnership. Forming an alliance with one these companies will give AVHC a national sales presence immediately at a minimal cost. During the coming weeks we will continue to work diligently on the completion of all agreements and pursuing every opportunity. We remain focused on the long-term success for Advanced Healthcare Technologies, Inc. as a business for our shareholders, our customers, our employees and global medical industry where we do business. We have reached a point in our Company's history where truly the future is upon us. Thank you for your continued support. God bless with Joy and Fulfillment Everyday. Sincerely, Randall L. Sulhoff, CEO, Advanced Healthcare Technologies, Inc. About Advanced Healthcare Technologies Advanced Healthcare Technologies, Inc. (OTCBB:AVHC) is a company that engages in the development and incubation of companies with products and services in the healthcare industry. Statements regarding financial matters in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. The company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements be subject to the safe harbors created thereby. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion